Amaç: Bu çalışmada, madde kullanımı veya temini nedeniyle denetimli serbestlik (DS) yükümlüsü olan ergenlerde, sosyal dışlanma, toplumsal aidiyet ve gelecek beklentisinin sağlıklı kontrollerle karşılaştırılması amaçlanmıştır.Yöntem: Çalışmaya, İstanbul’daki bir Çocuk ve Ergen Arındırma Merkezi (ÇEMATEM) Kliniği’ne uyuşturucu madde kullanımı veya temini gerekçesiyle DS yükümlüsü olarak başvuran 70 ergen ve psikiyatrik tanısı olmayan, yaş, cinsiyet ve sosyoekonomik düzeyi eşleştirilmiş 70 sağlıklı kontrol alınmıştır. Olgulara, sosyodemografik veri formu, Ergenler için Sosyal Dışlanma (Ostrasizm) Ölçeği, Ergenlerde Topluluk Hissi Ölçeği ve Ergen Gelecek Beklentileri Ölçeği uygulanmıştır. Bulgular: DS yükümlüsü ergenlerin, %85,7 (n=60)’si erkek ve yaş ortalaması 17.17 ± 0.85 olarak saptandı. Bu ergenlerin, %74,3'ünde (n=52) en az bir psikiyatrik hastalık mevcuttu. En sık saptanan ruhsal bozukluğun ise %80.2 oranla dikkat eksikliği hiperaktivite bozukluğu (DEHB) olduğu bulundu. Bu grupta, okulu bırakma ve ailede adli öykü oranı anlamlı düzeyde yüksekti. Yükümlü ergenlerin sosyal dışlanma ölçek puanları anlamlı düzeyde yüksek , toplumsal aidiyet ve gelecek beklentileri ölçek puanları ise anlamlı düzeyde düşüktü.Sonuç: Ergenlerde madde kullanımı; sosyal dışlanma, topluma aidiyet ve gelecek beklentilerini etkileyebilmektedir. DS yükümlüsü ergenlerde, psikososyal faktörler ve DEHB başta olmak üzere diğer psikopatolojilerin de irdelenmesi ve riskli grupların belirlenmesi önemlidir.

Background: Depression is a significant health issue among adolescents, often associated with decreased academic performance, self‐harm and increased suicide attempts. Suicidal and self‐harm behaviours are particularly concerning and are influenced by multiple factors beyond depression. This study aims to examine the factors contributing to suicidal behaviour and nonsuicidal self‐harm in adolescents diagnosed with major depressive disorder (MDD). Materials and Methods: This prospective study included adolescent patients aged 12–18 years diagnosed with MDD according to DSM‐5 criteria, referred to our Child and Adolescent Psychiatry Clinic between 1 February 2023 and 1 August 2023. Participants with intellectual disability, autism spectrum disorder, schizophrenia or other psychotic disorders were excluded. Data collection tools included the Sociodemographic Data Form, Inventory of Statements About Self‐Injury, Child Depression Inventory, Borderline Personality Inventory (BPI), Toronto Alexithymia Scale and Child and Youth Resilience Measure‐12 (CYRM‐12). Data were analysed using SPSS25.0. Results: Out of the 185 participants initially screened, 153 completed the study and were evenly divided into three groups: those who had never engaged in self‐harm or attempted suicide ( n = 51), those who had engaged in self‐harm at least once but had not attempted suicide ( n = 51) and those who had both engaged in self‐harm and attempted suicide ( n = 51). There were no significant differences in sociodemographic variables among the groups. Cutting was identified as the most common method of self‐harm (84.3%), followed by scratching (72.5%). In terms of resilience, measured by the CYRM‐12, the group with no history of self‐harm or suicide attempts had significantly higher scores (M = 36.55) than the self‐harm only group (M = 32.83) and the self‐harm plus suicide attempt group (M = 31.03) ( p < 0.001). For the BPI, the highest scores were observed in the group that had both engaged in self‐harm and attempted suicide (M = 29.28), followed by the self‐harm only group (M = 24.91) and the no self‐harm or suicide group (M = 19.26) ( p < 0.001). Conclusion: Adolescents with MDD who exhibit suicidal or self‐harm behaviours have higher borderline personality traits and alexithymia levels, and lower resilience compared to their counterparts without such behaviours. These findings suggest the importance of early identification and intervention targeting these factors to mitigate the risk of self‐harm and suicidal behaviour in depressed adolescents.

Introduction: Personality organization, defense mechanisms, psychological resilience, and treatment motivation are key psychological constructs that influence both the development and treatment outcomes of substance use disorders (SUD). The aim of this study is to investigate the relationships between treatment motivation, acute remission rates, personality organization, and psychological resilience in patients diagnosed opioid use disorder (OUD) and polysubstance use disorder (PSUD). Method: The study included 30 patients with opioid use disorder (OUD), 30 with polysubstance use disorder (PSUD), all diagnosed according to DSM-5 criteria, and 30 healthy controls (HC). Participants with OUD and PSUD were receiving inpatient treatment in this prospective case-control study. The study utilized the following instruments: Sociodemographic Data Form, Resilience Scale for Adults (RSA), Personality Organization Diagnostic Form, Motivation for Treatment Scale (MfTS), and Addiction Profile Index. MfTS and RSA were administered once more during follow-up assessments for patients who had achieved early remission. Results: PSUD group exhibited significantly higher scores for immature defense mechanisms compared to both OUD and HC groups, while mature defenses were significantly lower in both SUD groups relative to controls (p < 0.001). A significant positive correlation was identified between mature defenses and both treatment motivation and resilience levels (p < 0.05), while mature defenses showed a negative correlation with addiction severity (p < 0.05). Resilience levels emerged as a significant predictor of early remission (p = 0.011), and mediation analysis confirmed that resilience mediated the relationship between mature defenses and addiction severity (β= -0.151, 95% CI: -0.266 to -0.042). Conclusion: Mature defense mechanisms and resilience predict early remission and reducing addiction severity.

: This study from Istanbul aimed to compare the child and adolescent psychiatric admissions and diagnosis rates between the first 3 months of the pandemic, the previous 3 months in the same year, and the same months in the previous year. : Children and adolescents were grouped according to the admission dates. Group A, between March 11 and June 1, 2020; Group B, between January 1 and March 11, 2020; and Group C, between March 11 and June 1, 2019. Only clinical interviews and diagnoses according to Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version (K-SADS-PL) interview were included. : Autism spectrum disorder (ASD), obsessive-compulsive disorder (OCD)/tic disorder, and intellectual disability (ID) diagnoses were higher in group A than in groups B and C (for ASD, 6.4%, 4.3%, and 3.6%; for OCD/tic disorder, 2.9%, 1.8%, 1.7%; for ID, 3.7%, 2.5%, and 2.1%, respectively) (P < .001). Attention-deficit hyperactivity disorder (ADHD) diagnosis was higher in group A than in only group B (59.8% and 49.7%, respectively) (P < 0.001). Depression was higher in group A than in only group C (4.1% and 2.2%, respectively) (P < .001). Conduct disorder (CD) diagnosis was lower in group A than in only group B (3.6% and 6.4%, respectively) (P < .05). : Child psychiatry diagnosis rates were found to change significantly during the initial phase of the pandemic period. Among the referrals, ASD, OCD, Tic disorder, ID, ADHD, and depression admissions were significantly higher. The rate of pediatric neurodevelopmental disorders, particularly ASD, increased during the initial phase of the COVID-19 pandemic.

Anxiety comorbidity in bipolar disorder (BD) is important and thus significantly affects the course of BD and its outcomes. The treatment of generalized anxiety disorder comorbid with BD involves certain challenges, as antidepressant medications, which are standard in the treatment of anxiety disorder, have the risk of shifting to manic episodes and rapid cycling. In this case report, the response to agomelatine treatment in generalized anxiety disorder comorbid with bipolar 1 disorder was evaluated.